Rescue medication
<p>The Effect of Baseline Rescue Medication Use on Efficacy and Safety of Nebulized Glycopyrrolate Treatment in Patients with COPD from the GOLDEN 3 and 4 Studies</p>
... baseline rescue medication use, whereas lung function and PRO scores were generally worse in subgroups with higher baseline rescue medication ...as rescue medication use ...
10
<p>Evaluation of rescue medication use and medication adherence receiving umeclidinium/vilanterol versus tiotropium bromide/olodaterol</p>
... of rescue medication units was captured during the entire post-index ...index medication (de fi ned as a gap in therapy of 45 days from the dispense date for a retail pharmacy fi ll or 115 days from ...
14
Palonosetron versus ondansetron as rescue medication for postoperative nausea and vomiting: a randomized, multicenter, open-label study
... Patients were assessed for their overall response to the rescue medication, and discharge from the PACU was not affected by study participation. Baseline assessments occurred at a screening visit within 2 ...
8
Treatment of irritable bowel syndrome with diarrhoea using titrated ondansetron (TRITON): study protocol for a randomised controlled trial
... days rescue medication used over 12 weeks, abdominal pain score, HADS depression and anxiety scores, SF-LDQ score, IBS-QOL score and sub- scales, and PHQ-12 and IBS-SSS severity ...
12
Health resource utilization for inpatients with COPD treated with nebulized arformoterol or nebulized formoterol
... despite the availability of approved effective nebulized treat- ments, there is limited comparative evidence between these agents. Results from a clinical trial reported no significant differences between nebulized ...
9
All triptans are not the same
... of rescue medication within 24 hours, eletriptan appears to offer a clear advantage over all the other triptans, with the 80-mg dose showing a sustained response rate of 57%, while rizatriptan offers the ...
6
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
... ± rescue medication), (b) recurrence, assessed as sta- ted in the protocol, ...of rescue medication within 48 h), (d) and the number of pain relief episodes at 2 h (defined as a decrease in ...
8
A randomized, parallel-group study to evaluate the efficacy of umeclidinium/vilanterol 62.5/25 µg on health-related quality of life in patients with COPD
... was applied whereby inference for a test in the predefined hierarchy was dependent upon statistical significance having been achieved for previous tests in the hierarchy. The hierarchy consisted of UMEC/VI compared with ...
9
Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score
... with rescue medications, which may alleviate ...and rescue medication score be used as the primary outcome measure ...and medication score as a standard- ized method to balance both symptoms ...
9
Efficacy and safety of QVA149 compared to the concurrent administration of its monocomponents indacaterol and glycopyrronium: the BEACON study
... of rescue medication use, e-diary data with recording of daily clinical symptoms on the scale of 0–3 (where 0 refers to no symptoms) over the study period of 4 weeks, and safety and tolerability (adverse ...
8
Addressing unmet needs in the treatment of COPD
... daily rescue medication use and the percentage of days without use of rescue medication compared with glycopyrronium and open label tiotropium ...
12
A randomised multicentre trial of acupuncture in patients with seasonal allergic rhinitis – trial intervention including physician and treatment characteristics
... plus rescue medication (RM) with non-penetrating sham acupuncture (Sham) plus RM and with RM alone in the treatment of ...allergy medication; and ability to complete a symptom diary, including ...
10
Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial
... Background: The PRESTO study of non-invasive vagus nerve stimulation (nVNS; gammaCore®) featured key primary and secondary end points recommended by the International Headache Society to provide Class I evidence that for ...
9
Rescue analgesic Medication Use by Patients Treated With Triamcinolone Acetonide Extended-Release for Knee Osteoarthritis Pain: Pooled Analysis of Three Phase 2/3 Randomized Clinical Trials
... for rescue medication to be issued to participants for use as needed to manage uncontrolled index-knee pain ...Measuring rescue medication use can provide important information on the ...
10
Safety and efficacy of fluticasone/formoterol combination therapy in adolescent and adult patients with mild-to-moderate asthma: a randomised controlled trial
... Probably the most important and clinically relevant endpoint for patients is disease control. This was evalu- ated in this study by analysing the number of asthma control days, asthma exacerbations, rescue ...
15
The Pharmacy-Level Asthma Medication Ratio and Population Health
... correlation function of controller and rescue medication fills illustrates alignment for the timing of fill peaks and valleys consistent with the presumed seasonal variation. A Ph-AMR calculated at various ...
11
Montelukast, Compared With Fluticasone, for Control of Asthma Among 6- to 14-Year-Old Patients With Mild Asthma: The MOSAIC Study
... Methods. The Montelukast Study of Asthma in Chil- dren (MOSAIC study) was a 12-month, multicenter, ran- domized, double-blind, noninferiority trial to determine the effect of once-daily, orally administered montelukast ...
12
A STUDY COMPARING RESCUE MEDICATIONS: ARFORMOTEROL AND SALBUTAMOL NEBULIZATION IN EXACERBATION OF NON SEVERE ASTHMA AT A TERTIARY CARE CENTER, NOT NEEDING HOSPITALIZATION
... reliever medication, in patients with exacerbation of non-severe ...a rescue medication, in acute non- severe asthma, not requiring hospitalisation, at a tertiary care ...
6
<p>Daily patient-reported health status assessment improvements with benralizumab for patients with severe, uncontrolled eosinophilic asthma</p>
... time. Rescue medication use was recorded as the total number of puffs used in each recall period (night-time and ...Daily rescue medication use was the sum of the two daily ...requiring ...
13
Assessing the use of BreatheSmart® mobile technology in adult patients with asthma: a remote observational study
... If Cohero Health mobile technology proves easy to use at home, it will validate this technology as a cost-effective solution to improve medication adherence and outcomes in patients with asthma using daily ICS. If ...
6